scholarly article | Q13442814 |
P356 | DOI | 10.1046/J.1365-2168.1998.00915.X |
P698 | PubMed publication ID | 9823912 |
P50 | author | Markus Schwaiger | Q57016855 |
P2093 | author name string | Römer W | |
Weber WA | |||
Ziegler SI | |||
Präuer HW | |||
Treumann T | |||
P433 | issue | 11 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | glucose | Q37525 |
positron emission tomography | Q208376 | ||
P304 | page(s) | 1506-1511 | |
P577 | publication date | 1998-11-01 | |
P1433 | published in | British Journal of Surgery | Q4970212 |
P1476 | title | Controlled prospective study of positron emission tomography using the glucose analogue [18f]fluorodeoxyglucose in the evaluation of pulmonary nodules | |
P478 | volume | 85 |
Q36411892 | A method for model-free partial volume correction in oncological PET. |
Q53158932 | Assessment of pulmonary melanoma metastases with 18F-FDG PET/CT: which PET-negative patients require additional tests for definitive staging? |
Q86628849 | Characterization of solitary pulmonary nodules with 18F-FDG PET/CT relative activity distribution analysis |
Q34013807 | Clinical imaging of cancer metastasis. |
Q35769878 | Comparing 18F-Fluorodeoxyglucose Positron Emission Tomography and Video-assisted Thoracoscopic Surgery in the Evaluation of Small Pulmonary Nodules in Patients with a History of Malignancy |
Q57006924 | Computed tomography of pulmonary metastases from osteosarcoma: the less poor technique. A study of 51 patients with histological correlation |
Q48538174 | Correction for Partial Volume Effect Is a Must, Not a Luxury, to Fully Exploit the Potential of Quantitative PET Imaging in Clinical Oncology |
Q44212161 | Diagnostic accuracy of semiquantitative analysis of positron emission tomography in radiologically indeterminate lung lesions |
Q44598412 | Differentiating Solitary Pulmonary Metastases in Patients with Renal Cell Carcinomas by <sup>18</sup>F-Fluoro-2-Deoxyglucose Positron Emission Tomography – A Preliminary Report |
Q44365801 | Differentiating solitary pulmonary metastases in patients with extrapulmonary neoplasmas using FDG-PET. |
Q35008678 | Early lung cancer detection and treatment strategies |
Q22306068 | Evaluation of Patients With Pulmonary Nodules: When Is It Lung Cancer? |
Q43634477 | FDG-PET for detection of pulmonary metastases from malignant primary bone tumors: comparison with spiral CT. |
Q44549060 | Fluorodeoxyglucose-positron emission tomography in adenocarcinomas of the distal esophagus and cardia |
Q46948766 | Impact of dual-time-point (18)F-FDG PET imaging and partial volume correction in the assessment of solitary pulmonary nodules |
Q37643555 | Monitoring and management of lung cancer patients following curative-intent treatment: clinical utility of 2-deoxy-2-[fluorine-18]fluoro-d-glucose positron emission tomography/computed tomography |
Q33902547 | Novel approaches to locally advanced unresectable non-small cell lung cancer |
Q34569986 | Positron emission tomography in the diagnosis and staging of lung cancer: a systematic, quantitative review |
Q34088981 | Quantitative assessment of tumor metabolism using FDG-PET imaging |
Q35894712 | Radionuclide imaging of thoracic malignancies |
Q46104419 | Solitary pulmonary nodules and masses: a meta-analysis of the diagnostic utility of alternative imaging tests |
Q37210598 | The role of positron emission tomography in the management of non-small cell lung cancer. |
Q43681808 | Validation of FDG positron emission tomography for differentiation of unknown pulmonary lesions |
Q35033424 | Value of FDG-PET in the management of non-small cell lung cancer. |
Q82563242 | [Positron emission tomography for the study of solitary pulmonary nodules] |
Q53672343 | [Positron emission tomography in respiratory medicine] |
Search more.